Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : World Outlook -- Ignore unavailable to you. Want to Upgrade?

To: Les H who wrote (49349)	12/9/2025 11:27:44 AM
From: Les H	Read Replies (1) \| Respond to of 49637

Armed clashes between Thailand and Cambodia entered a second day on Tuesday, both sides said, in defiance of calls from the United States to stop fighting and adhere to a months-old Trump-backed peace deal that now looks on the brink of complete collapse. At least eight people have been killed since the latest skirmishes began, according to reports from both sides. By Tuesday, the fighting had spread to more points along the disputed border, with accusations of rocket strikes and drone attacks in some areas. About 400,000 people living along the border that divides the Southeast Asian countries have been evacuated in the latest flare-up. And Thai Foreign Minister Sihasak Phuangketkeow hinted the clashes could escalate, telling CNN in a sit-down interview that military action would continue “until we feel that sovereignty and territorial integrity are not challenged.” The fighting, over decades-old competing territorial claims along their 500-mile (800-kilometer) land border is the heaviest between Thailand and Cambodia since a deadly five-day conflict in July. The already shaky peace agreement, signed in October in the presence of US President Donald Trump, who hailed it as proof of his ability to end wars, now looks in danger of disintegrating. Thailand and Cambodia are fighting again, leaving a Trump-brokered peace agreement on brink of collapse. What happened?